Medication Monitor

Generic Name (Trade Name—Company)
October 25, 2018


(Robaxin—Endo Pharmaceuticals)
Two lots of recalled product have incorrect daily dosing information on label

Endo Pharmaceuticals is voluntarily recalling two lots of methocarbamol (Robaxin) 750-mg tablets in 100-count bottle pack. The product labels contain incorrect daily dosing information, misstating the daily dose as "two to four tablets four times daily" rather than the correct dosage of "two tablets three times daily."

Patients who follow the label directions may experience significant drowsiness or dizziness that would put them at risk of falls or an overdose that could result in seizures, coma, or death. 

The product is indicated as an adjunct therapy to rest, physical therapy, and other measures to relieve the discomfort associated with acute, painful musculoskeletal conditions. 

The recall includes the product lot 216702P1, expiration date September 2020; and lot 220409P1, expiration date January 2021.

To date, Endo Pharmaceuticals has not received any reports of adverse events related to this recall.